DRMA: Dermata Therapeutics, Inc. Stock

by  •  • Comments Off on DRMA: Dermata Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 4.69
Enterprise Value ($M) -1.45
Book Value ($M) 4.74
Book Value / Share 1.19
Price / Book 0.99
NCAV ($M) 4.74
NCAV / Share 1.19
Price / NCAV 0.99

Profitability (mra)
Return on Invested Capital (ROIC) -2.38
Return on Assets (ROA) -1.41
Return on Equity (ROE) -1.77

Liquidity (mrq)
Quick Ratio 3.44
Current Ratio 3.44

Balance Sheet (mrq) ($M)
Current Assets 6.69
Assets 6.69
Liabilities 1.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 48.45
01-28 13G Intracoastal Capital, Llc 6.70 82.34

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 26,945 65,161 41.35
2025-03-13 16,606 60,506 27.45
2025-03-12 18,737 86,858 21.57
2025-03-11 23,334 116,962 19.95
2025-03-10 59,549 163,368 36.45

(click for more detail)

Similar Companies
DERM – Journey Medical Corporation DMAC – DiaMedica Therapeutics Inc.
DNTH – Dianthus Therapeutics, Inc. DRRX – DURECT Corporation
DRUG – Bright Minds Biosciences Inc.


Financial data and stock pages provided by
Fintel.io